Tower Research Capital LLC (Trc) Chroma Dex Corp. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,268 shares of CDXC stock, worth $6,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,268
Previous 3,370
62.37%
Holding current value
$6,872
Previous $12,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$18.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.9 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$14 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.03 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.26 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $370M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...